PharmaBoardroom

Interview with Albert Saporta, President and CEO, Stallergenes

Can you highlight some of the more recent milestones for Stallergenes? Stallergenes has been successful over recent years for several reasons, the…

Interview with Michel Abiteboul, VP Corporate Development of…

As Quintiles is present in all major pharmaceutical markets worldwide, what’s the relevance of the French affiliate and what role it plays…

Interview with Emilio Sardi, Executive Vice President,…

Mr. Sardi, Exec-VP of Tecnoquímicas, the No. 1 producer and distributor of generic pharmaceutical drugs in Colombia, explains what makes…

Interview with Christian Deleuze, President, Daiichi Sankyo…

When we met your Italian colleague, he noted that they had tripled their turnover in a five year period. You haven’t done badly yourself in the…

Interview with Pascal Brière , President, Biogaran

Biogaran was an initiative from Servier in the mid 1990s before there was even a generic pharmaceutical market in France. Could you speak of your…

Interview with Sabine Dandiguian, President, Janssen-Cilag France

Janssen-Cilag is involved in not only selling its products in France but research and production as well. As France is a leading subsidiary, can you…

Interview with Charles Woler, CEO, Endotis Pharma

Endotis was incorporated in 2003 on the basis of a technology transfer from on a French public research institution. Can you elaborate on the origins?…

Interview with Jacques de Chilly, Executive Director, Aderly…

This interview was conducted with Jacques de Chilly and Theirry de Lumley of Aderly hereafter referred to as J.C. and T.L. respectively. Aderly was…

Interview with Philippe Ranty, Managing Director, Actavis France

Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later - in late…

Interview with Patrick Oscar, Director General, GERS –…

CIP and GERS have very unique relationships with the pharmaceutical industry. Could you elaborate on the role of these two bodies? Club…

Interview with Philippe Archinard, President, Lyonbiopôle

As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the…

Interview with Arnim Jost, General manager, Cegedim Deutschland…

You joined Cegedim in summer 2006 eleven months before its merger with Dendrite in 2007 that created the world leader in pharmaceutical CRM. How would…

Tagged with